Meeting
2019 Genitourinary Cancers Symposium
Overall survival outcomes with the use of adjuvant chemotherapy, radiation therapy and hormone therapy in high-risk, very-high-risk and node-positive prostate cancer post radical prostatectomy: A NCDB analysis.
Authors
Alina Basnet
SUNY Upstate Medical University, Syracuse, NY
Alina Basnet , Margaret K Formica , Poornima Ramadas , Sam Benjamin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 118)
DOI
10.1200/JCO.2019.37.7_suppl.118
Abstract #
118
Poster Bd #
B20
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
High-risk nonmetastatic prostate cancer in the elderly: Does adjuvant chemotherapy affect survival?
First Author: Komal Akhtar
Poster
2018 Genitourinary Cancers Symposium
Randomised phase 3 trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for high risk, clinically localized prostate cancer: ENZARAD (ANZUP 1303).
First Author: Scott Williams
Poster
2018 Genitourinary Cancers Symposium
Optimal timing of post-prostatectomy radiotherapy for prostate cancer with high-risk pathologic features: A multi-institutional analysis.
First Author: William L. Hwang
Poster
2016 ASCO Annual Meeting
The addition of adjuvant chemotherapy to radiation in high risk endometrial cancer: Survival outcomes and patterns of care.
First Author: Dustin Boothe